On Question 4 And More: All About The Psychedelics Ballot Initiative
September 2, 2024
An interview with Massachusetts for Mental Health Options Educational Outreach Director Graham Moore
An interview with Massachusetts for Mental Health Options Educational Outreach Director Graham Moore
A conversation with Grassp Health CEO Veronica Santarelli about business, patients, and priorities
Founder of Connecticut for Accessible Psychedelic Medicine tells TJM: “When people see that their own lives can improve, it builds a community [that] is willing to fight.”
“We can get smaller businesses credits, we can make it easier for them to do business and to compete.”
“One of the biggest misconceptions I hear is that psychedelics are ‘white people stuff.’ This is far from the truth.”
Veteran impersonation act outrages activists, further muddies grassroots waters
Advocates decry “shadow campaign” subverting ballot initiative to legalize psychedelics in Massachusetts
“We knew we wanted to do something in psychedelics as we believed [Amanita muscaria] could be disruptive to the existing medicinal landscape.”
From generating buzz around their cause to getting heard on Beacon Hill, psychedelics advocates had a big March. But underneath the wins, fractures in the movement as well as external opposition could undermine legalization efforts.
An interview with Jamie Morey, founder of Parents for Plant Medicine: “We have to do better … There is no justification for building a system that creates a disgustingly high price tag to access plant medicine like psilocybin.”
